Skip to main content
. 2021 Dec 9;126(5):726–735. doi: 10.1038/s41416-021-01620-6

Table 2.

Tumour mutation analysis (KRAS/BRAF) in metastatic colorectal cancer patients with cytoreductive surgery and HIPEC (CRS-HIPEC) (n = 174).

Parameter mutKRAS (n = 59) mutBRAF (n = 43) Double wt (n = 72) P
n % n % n %
Gender
 Female 39 66.1 32 74.4 41 56.9 0.163
Age, median (range) 59.0 23–77 60.9 33–75 57.3 22–76 0.091
pT-stage
 T1-2 0 0 1 2.4 0 0 0.686a
 T3 21 38.2 23 54.8 28 43.1
 T4 34 61.8 18 42.9 37 56.9
N-stage
 N0 17 29.3 14 32.6 17 25.0 0.128a
 N1 26 44.1 11 25.6 22 31.4
 N2 16 27.6 18 41.9 31 44.3
 Missing 0 0 2
Grade of tumour differentiation 0.003
 Poorly 6 12.3 16 40.0 22 40.7
 Moderate 40 81.6 21 52.5 31 57.4
 Well 3 6.1 3 7.5 1 1.9
 Not reported 10 3 18
Signet ring cells
 Yes 1 2.7 5 15.6 9 20.0 0.039
 No 36 97.3 27 84.4 36 80.0
 Not reported 22 11 27
Tumour location 1
 Right colon 18 30.5 30 69.8 25 34.7 <0.001
 Left colon and rectum 41 69.5 13 30.2 47 65.3
Tumour location 2
 Colon 54 91.5 43 100 61 84.7 0.012
 Rectum 5 8.5 0 0 11 15.3
Peritoneal metastases
 Synchronous 19 32.2 11 25.6 26 36.1 0.513
 Metachronous 40 67.8 32 74.4 46 63.9
Chemoterapy earlier than CRS-HIPEC 0.024
 Yes 33 55.9 31 72.1 56 77.8
 No 26 44.1 12 27.9 16 22.2
CEA (µg/L)
 < 5 23 39.0 24 55.8 51 71.8 0.001
 >5 36 61.0 19 44.2 20 28.2
 Missing 1
PCI
 1–10 35 59.3 28 66.1 42 58.3 0.997a
 11–20 20 33.9 12 27.9 26 36.1
 >20 4 6.8 3 7.0 4 5.6
MSI 0 0 12 29.3 3 8.1 <0.001
MSS 33 100 29 70.7 34 91.9
Missing 26 2 35
mutBRAF with MSI 0 0 12 29.3 0 0 <0.001
mutBRAF with MSS 0 0 29 70.7 0 0
wtBRAF 59 100 0 0 72 100
Missing 0 2 0
Median time from peritoneal metastasis to HIPEC (months) 3 0–43 3 0–24 3 0–53 0.889
Median time from primary cancer to HIPEC (months) 13 0–69 13 0–55 10 0–81 0.995
Median DFI (months)
 0 31 52.5 23 53.5 42 58.3 0.704
 1–12 14 23.7 8 18.6 10 13.9
 >12 14 23.7 12 27.9 20 27.8
Type of recurrence at 5 years 0.819
 Local recurrence 18 30.5 13 30.2 17 23.9
 Distal metastasis 20 33.9 16 37.2 26 36.6
 Both 13 22.0 8 18.6 12 16.9
 Alive 8 13.6 6 14.0 16 22.5

aLinear-by-linear association.

Statistically significant p < 0.05 values are in bold.